← Leaderboards
Marcus T Cicerone
Georgia Institute Of Technology
$719,143
Attributed
$971,610
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $238.5K · FY2020–25$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$971,610 · 3
By mechanism
R21$961,614 · 2
R13$9,996 · 1
Top collaborators
- Wei-Wen Chen2 shared
- Sung Min Han2 shared
Most similar at Georgia Institute Of Technology
Same institution · by research overlap
- Stephen Paul Diggle$3,215,888
- Fredda H. Blanchard-Fields$3,490,988
- Peter Yunker$1,638,968
- Robert M Dickson$9,633,086
- Woon-Hong Yeo$2,870,531
Others in their field
Other Emerging Leaders on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Joel A Lipkin · Four Points Technology, Llc$181,896,915
- Lynn Briscoe · Leidos Biomedical Research, Inc.$119,691,178
- Terry Drinkwine · Carahsoft Technology Corporation$93,011,563
Research focus
ImageSignal TransductionLabelEnvironmentImaging ApproachTissuesBiologyMetabolicCellsLipidsMetabolismMapsHeterogeneityPlayExcisionBiologicalBaseAlzheimer&AposFruitIn SituComplexDiagnosticDetectionClinical Application
Grant awards (6)
Investigating spatial and temporal heterogeneity in mitochondria during aging using in vivo high-content chemical imaging$182,175
R21 · FY2025 · AG
Investigating spatial and temporal heterogeneity in mitochondria during aging using in vivo high-content chemical imaging$196,525
R21 · FY2024 · AG
Label-Free Cell-Resolved Metabolomics for Tumor Microscopy$138,260
R21 · FY2022 · CA · contact PI
Label-Free Cell-Resolved Metabolomics for Tumor Microscopy$228,534
R21 · FY2021 · CA · contact PI
Biomedical Raman Imaging Workshop$9,996
R13 · FY2021 · EB · contact PI
Label-Free Cell-Resolved Metabolomics for Tumor Microscopy$216,120
R21 · FY2020 · CA · contact PI